Comorbidities in Heart Failure.

about

Comorbidities in Heart Failure.

Item

http://www.wikidata.org/entity/Q47744924

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh

2017年學術文章

@zh-hant

name

Comorbidities in Heart Failure.

@en

Comorbidities in Heart Failure.

@nl

type

Item

label

Comorbidities in Heart Failure.

@en

Comorbidities in Heart Failure.

@nl

prefLabel

Comorbidities in Heart Failure.

@en

Comorbidities in Heart Failure.

@nl

P1476

Comorbidities in Heart Failure.

@en

P2093

Adriaan A Voors

http://www.w3.org/2001/XMLSchema#string

Haye H van der Wal

http://www.w3.org/2001/XMLSchema#string

Peter van der Meer

http://www.w3.org/2001/XMLSchema#string

Vincent M van Deursen

http://www.w3.org/2001/XMLSchema#string

P2860

Dipeptidyl peptidase-4 inhibitors and risk of heart failure in type 2 diabetes: systematic review and meta-analysis of randomised and observational studies

2013 ACCF/AHA guideline for the management of heart failure: executive summary: a report of the American College of Cardiology Foundation/American Heart Association Task Force on practice guidelines

Heart failure outcomes with empagliflozin in patients with type 2 diabetes at high cardiovascular risk: results of the EMPA-REG OUTCOME® trial.

Sleep-disordered breathing in patients with symptomatic heart failure: a contemporary study of prevalence in and characteristics of 700 patients

Meta-Analysis of Effects of Sodium-Glucose Cotransporter 2 Inhibitors on Cardiovascular Outcomes and All-Cause Mortality Among Patients With Type 2 Diabetes Mellitus.

Pharmacotherapy for comorbidities in chronic heart failure: a focus on hematinic deficiencies, diabetes mellitus and hyperkalemia.

Heart failure and chronic obstructive pulmonary disease: diagnostic pitfalls and epidemiology

Statins suppress apolipoprotein CIII-induced vascular endothelial cell activation and monocyte adhesion

Renin-Angiotensin System Inhibition, Worsening Renal Function, and Outcome in Heart Failure Patients With Reduced and Preserved Ejection Fraction: A Meta-Analysis of Published Study Data.

Heart failure events with rosiglitazone in type 2 diabetes: data from the RECORD clinical trial.

P304

35-66

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/164_2017_27

http://www.w3.org/2001/XMLSchema#string

P478

243

http://www.w3.org/2001/XMLSchema#string

P577

2017-04-06T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28382470

http://www.w3.org/2001/XMLSchema#string